News

Presentation at the Headache Cooperative of the Northeast

March 16, 2026

It was an honor to speak at the annual Winter HCNE Headache Symposium, where I also led the discussion for two presentations moderated by Dr. Steven Baskin. The first, by Dr. Mario Peres of São Paulo—President of the International Headache Society—explored the relationship between religiosity, spirituality, and headache. The second, by Dr. Peter McAllister, examined GLP-1 receptor agonists in headache medicine, highlighting what is known, what is possible, and what remains uncertain. Both talks addressed topics not typically featured at headache meetings and sparked a lively discussion.

Written by
Alexander Mauskop, MD
Continue reading
August 8, 2026
Sugar is bad for your brain, even before you are born.
Sugar consumed in the first two years of life increases the risk of dementia.
Read article
August 6, 2026
Research
An Old Medicine that Could Make Brain Stimulation Work Better for Depression and Other Neurological Conditions
A 2022 clinical trial from the University of Calgary found that adding low‑dose D‑cycloserine (DCS), a partial NMDA‑receptor agonist, to intermittent theta‑burst stimulation (iTBS) significantly increased response and remission rates in depression without serious side effects. Early follow‑up data suggest that timing, dose, and drug levels matter, and raise the possibility that this DCS‑TMS approach could eventually be applied to other neurological conditions—such as migraine, postconcussion syndrome, brain fog, and long COVID
Read article
Insights from Dr. Alexander Mauskop on headaches and migraines
Subscribe to the Blog.
Subscribe
Subscribe